Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Publication year range
1.
Pan Afr Med J ; 29: 134, 2018.
Article in French | MEDLINE | ID: mdl-30050598

ABSTRACT

We here report the case of a 47-year old female patient with acute coronary syndrome associated with possible arterial embolism of the right lower limb. During examination we detected G201210A Mutation of the Prothrombin Gene associated with lupus anticoagulant factor.


Subject(s)
Acute Coronary Syndrome/diagnosis , Embolism/diagnosis , Prothrombin/genetics , Acute Coronary Syndrome/genetics , Embolism/genetics , Embolism/pathology , Female , Humans , Lupus Coagulation Inhibitor/genetics , Middle Aged , Mutation
2.
Enferm Infecc Microbiol Clin ; 25(7): 437-40, 2007.
Article in Spanish | MEDLINE | ID: mdl-17692211

ABSTRACT

BACKGROUND: This study examines the prevalence of primary resistance to antiretroviral drugs in patients diagnosed with HIV infection during 2002 to 2005 and determines the clinical and epidemiological characteristics of this population. METHODS: A prospective analysis of genotypic resistance was carried out in 125 patients by gene sequencing (88.0% diagnosed in 2002, 28.9% in 2003-2004, and 87.9% in 2005). Thirteen patients had a diagnosis of recent primary infection. RESULTS: Sixteen patients (12.8%) carried viruses with at least one drug-resistance mutation; among them, 4 had recent infection (30.8%) and 12 chronic infection or infection of unknown duration (10.7%). Six patients (4.8%) presented at least one resistance mutation to nucleoside/tide reverse transcriptase inhibitors, 9 patients (7.2%) to non-nucleoside/ tide reverse transcriptase inhibitors inhibitors and 2 patients (1.6%) to protease inhibitors. One patient (0.8%) harbored a multidrug-resistant variant. The frequency of primary resistance was higher in patients with HIV subtype B (15.5%), in the homosexual/bisexual population (17.9%), and in patients diagnosed in 2005 (17.9%). Prevalence increased from 9.3% in 2002 to 16.3% in 2005 in chronically infected patients or those with unknown duration of the infection. CONCLUSIONS: Primary resistance to antiretroviral drugs is high in both recent and chronic HIV infection and has increased in recent years. Genotype resistance testing in patients with a diagnosis of HIV infection is recommended before beginning antiretroviral therapy.


Subject(s)
Anti-HIV Agents/pharmacology , Drug Resistance, Viral , HIV Infections/drug therapy , HIV-1/drug effects , Adult , Anti-HIV Agents/therapeutic use , Atlantic Islands/epidemiology , Drug Resistance, Multiple, Viral/genetics , Drug Resistance, Viral/genetics , Female , Genotype , HIV Infections/epidemiology , HIV Protease/genetics , HIV Protease Inhibitors/pharmacology , HIV Reverse Transcriptase/genetics , HIV-1/genetics , Humans , Male , Middle Aged , Mutation, Missense , Point Mutation , Prospective Studies , Reverse Transcriptase Inhibitors/pharmacology , Spain/epidemiology , Time Factors
SELECTION OF CITATIONS
SEARCH DETAIL
...